Clinical Trial

Ticagrelor and ASA vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patients With Acute Coronary Syndrome

Study acronym: TACSI
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The study is a Randomised Registry-based Clinical Trial (RRCT) to assess whether dual antiplatelet therapy with ticagrelor and ASA compared to ASA alone improves outcome after isolated CABG in patients with acute coronary syndrome.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2018-06-15; most recent amendment 2025-08-29.
Status change: Recruiting → Active, Not Recruiting 2024-09-02
Status change: Not Yet Recruiting → Recruiting 2018-09-18
Trial Details
NCT Number NCT03560310
Lead Sponsor Vastra Gotaland Region
Collaborators: Gothia Forum - Center for Clinical Trial, Göteborg University
Conditions Acute Coronary Syndrome
Enrollment 2,201 participants
Start Date 2018-06-29
Primary Completion 2025-03-13 (estimated)
Study Completion 2035-02-15 (estimated)
Updated on ClinicalTrials.gov 2025-09-02